NewGen BioPharma (NEWG) Price & Analysis

Q: What was NewGen BioPharma Corp.’s price range in the past 12 months?

NewGen BioPharma Corp. lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.

Q: What is NewGen BioPharma Corp.’s market cap?

NewGen BioPharma Corp.’s market cap is $2.26K.

Q: When is NewGen BioPharma Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Q: Is NewGen BioPharma Corp. overvalued?

According to Wall Street analysts NewGen BioPharma Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does NewGen BioPharma Corp. pay dividends?

NewGen BioPharma Corp. does not currently pay dividends.

Q: What is NewGen BioPharma Corp.’s EPS estimate?

NewGen BioPharma Corp.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does NewGen BioPharma Corp. have?

NewGen BioPharma Corp. has 22,600,000 shares outstanding.

Q: Which hedge fund is a major shareholder of NewGen BioPharma Corp.?

Currently, no hedge funds are holding shares in NEWG

Q: What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

5 Followers

NEWG Stock Chart & Stats

<$0.01

<$0.01(900.00%)

At close: Jul 21 4:00 PM EDT

<$0.01

<$0.01(900.00%)

Day’s Range― - ―

52-Week Range$0.01 - $0.01

Previous CloseN/A

Volume5.88K

Average Volume (3M)0.00

Market Cap

$2.26K

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-15.24

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding22,600,000

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

NEWG FAQ

What was NewGen BioPharma Corp.’s price range in the past 12 months?

NewGen BioPharma Corp. lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.

What is NewGen BioPharma Corp.’s market cap?

NewGen BioPharma Corp.’s market cap is $2.26K.

When is NewGen BioPharma Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were NewGen BioPharma Corp.’s earnings last quarter?

Currently, no data Available

Is NewGen BioPharma Corp. overvalued?

According to Wall Street analysts NewGen BioPharma Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does NewGen BioPharma Corp. pay dividends?

NewGen BioPharma Corp. does not currently pay dividends.

What is NewGen BioPharma Corp.’s EPS estimate?

NewGen BioPharma Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NewGen BioPharma Corp. have?

NewGen BioPharma Corp. has 22,600,000 shares outstanding.

What happened to NewGen BioPharma Corp.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of NewGen BioPharma Corp.?

Currently, no hedge funds are holding shares in NEWG

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NewGen BioPharma Corp.

Greenwind Holdings Inc. is a development-stage enterprise primarily focused on identifying and acquiring various investment opportunities. Established in 2010, the company was formerly known as NewGen BioPharma Corp. until its rebranding to Greenwind Holdings Inc. in April 2017. Its headquarters are located in Seattle, Washington.